Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $212.61 | 15 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Circassia Pharmaceuticals Inc | $77.35 | 6 | $0 (2020) |
| PFIZER INC. | $38.57 | 2 | $0 (2023) |
| Biohaven Pharmaceuticals, Inc. | $33.81 | 2 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $26.01 | 2 | $0 (2019) |
| Phadia US Inc. | $15.05 | 1 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $11.17 | 1 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $10.65 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $38.57 | 2 | PFIZER INC. ($38.57) |
| 2021 | $33.81 | 2 | Biohaven Pharmaceuticals, Inc. ($33.81) |
| 2020 | $12.59 | 1 | Circassia Pharmaceuticals Inc ($12.59) |
| 2019 | $50.98 | 4 | Circassia Pharmaceuticals Inc ($25.83) |
| 2018 | $10.93 | 1 | Circassia Pharmaceuticals Inc ($10.93) |
| 2017 | $65.73 | 5 | Circassia Pharmaceuticals Inc ($28.00) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: PAIN | ||||||
| 10/11/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: PAIN | ||||||
| 10/28/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: PRIMARY CARE | ||||||
| 09/24/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: PRIMARY CARE | ||||||
| 03/05/2020 | Circassia Pharmaceuticals Inc | DUAKLIR PRESSAIR (Drug), TUDORZA PRESSAIR | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: PULMONARYRESPIRATORY DISEASES | ||||||
| 10/29/2019 | Circassia Pharmaceuticals Inc | DUAKLIR PRESSAIR (Drug), TUDORZA PRESSAIR | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: PULMONARYRESPIRATORY DISEASES | ||||||
| 09/10/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: RESPIRATORY | ||||||
| 08/26/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.17 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/12/2019 | Circassia Pharmaceuticals Inc | TUDORZA PRESSAIR (Drug) | Food and Beverage | In-kind items and services | $11.29 | General |
| Category: PULMONARYRESPIRATORY DISEASES | ||||||
| 09/06/2018 | Circassia Pharmaceuticals Inc | TUDORZA PRESSAIR (Drug), NIOX VERO DEVICE | Food and Beverage | In-kind items and services | $10.93 | General |
| Category: PULMONARYRESPIRATORY DISEASES | ||||||
| 09/20/2017 | Circassia Pharmaceuticals Inc | TUDORZA PRESSAIR (Drug), NIOX VERO DEVICE | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: PULMONARYRESPIRATORY DISEASES | ||||||
| 08/09/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Food and Beverage | In-kind items and services | $10.65 | General |
| Category: RESPIRATORY | ||||||
| 06/16/2017 | Circassia Pharmaceuticals Inc | NIOX VERO DEVICE (Device) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: ALLERGY AND ASTHMA | ||||||
| 03/14/2017 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $15.05 | General |
| Category: Allergy/Immunology | ||||||
| 02/21/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA (Drug) | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 350 | 696 | $46,614 | $28,330 |
| 2022 | 9 | 393 | 660 | $44,525 | $28,129 |
| 2021 | 8 | 407 | 735 | $46,877 | $30,629 |
| 2020 | 8 | 474 | 919 | $61,940 | $35,944 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 55 | 154 | $14,840 | $9,944 | 67.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 63 | 106 | $15,395 | $7,980 | 51.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 42 | 42 | $7,980 | $5,448 | 68.3% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 12 | 15 | $3,900 | $2,453 | 62.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 31 | 31 | $1,395 | $570.09 | 40.9% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 48 | 173 | $865.00 | $555.33 | 64.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 57 | 133 | $1,064 | $453.53 | 42.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 14 | 14 | $560.00 | $437.50 | 78.1% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 14 | 14 | $475.00 | $429.64 | 90.5% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2023 | 14 | 14 | $140.00 | $60.06 | 42.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 61 | 110 | $15,500 | $9,898 | 63.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 70 | 153 | $14,535 | $8,723 | 60.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 52 | 52 | $9,880 | $6,918 | 70.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 38 | 38 | $1,710 | $715.16 | 41.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 21 | 23 | $690.00 | $677.10 | 98.1% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 57 | 140 | $700.00 | $441.29 | 63.0% |
| 81002 | Urinalysis, manual test | Office | 2022 | 65 | 115 | $920.00 | $395.44 | 43.0% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2022 | 15 | 15 | $450.00 | $301.05 | 66.9% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2022 | 14 | 14 | $140.00 | $60.56 | 43.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 81 | 221 | $20,995 | $13,852 | 66.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 59 | 59 | $11,210 | $8,041 | 71.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 59 | 86 | $11,180 | $6,592 | 59.0% |
| 90756 | Vaccine for influenza derived from cell cultures for injection into muscle, quadrivalent, antibiotic free, 0.5ml dosage | Office | 2021 | 25 | 25 | $625.00 | $625.00 | 100.0% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2021 | 61 | 165 | $825.00 | $523.38 | 63.4% |
| 81002 | Urinalysis, manual test | Office | 2021 | 77 | 134 | $1,072 | $463.17 | 43.2% |
About Dr. Sunitha Nambiar, M.D
Dr. Sunitha Nambiar, M.D is a Family Medicine healthcare provider based in Highland Park, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2007. The National Provider Identifier (NPI) number assigned to this provider is 1639376858.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sunitha Nambiar, M.D has received a total of $212.61 in payments from pharmaceutical and medical device companies, with $38.57 received in 2023. These payments were reported across 15 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($212.61).
As a Medicare-enrolled provider, Nambiar has provided services to 1,624 Medicare beneficiaries, totaling 3,010 services with total Medicare billing of $123,033. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Highland Park, MI
- Active Since 06/29/2007
- Last Updated 05/18/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1639376858
Products in Payments
- NURTEC ODT (Drug) $72.38
- TUDORZA PRESSAIR (Drug) $36.59
- DUAKLIR PRESSAIR (Drug) $27.13
- ImmunoCAP (Device) $15.05
- STIOLTO RESPIMAT (Drug) $13.98
- NIOX VERO DEVICE (Device) $13.63
- SPIRIVA (Drug) $12.03
- ENTRESTO (Drug) $11.17
- UTIBRON (Drug) $10.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Highland Park
Dr. Ruth Mays, Md, MD
Family Medicine — Payments: $3,743
Dr. Arthur Miller, Md, MD
Family Medicine — Payments: $1,709
Inna Hoffman, Apn, APN
Family Medicine — Payments: $1,500
Frederic Glatter, Md, MD
Family Medicine — Payments: $810.13
Branden Staller
Family Medicine — Payments: $442.61
Dr. Veena Korah, M.d, M.D
Family Medicine — Payments: $421.96